Watertown, MA, United States of America

Alfonso Vicente-Suarez

This inventor holds 1 USPTO granted patent. Top assignee: Sqz Biotechnologies Company. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alfonso Vicente-Suarez. Retrieved from https://idiyas.com/inventor/alfonso-vicente-suarez-deq5qrwk

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Alfonso Vicente-Suarez: Innovator in Immune Response Modification

Introduction

Alfonso Vicente-Suarez is a notable inventor based in Watertown, MA (US). He has made significant contributions to the field of biotechnology, particularly in the area of immune response modification. His innovative work has led to the development of a patent that addresses critical challenges in biomolecule delivery.

Latest Patents

Alfonso holds a patent titled "Intracellular Delivery of Biomolecules to Modify Immune Response." This patent represents a breakthrough in the ability to effectively deliver biomolecules within cells, which can have profound implications for therapeutic interventions.

Career Highlights

Alfonso Vicente-Suarez is currently employed at Sqz Biotechnologies Company, where he continues to push the boundaries of biotechnological advancements. His work at Sqz Biotechnologies focuses on developing novel approaches to enhance immune responses through innovative delivery methods.

Collaborations

Alfonso collaborates with Leeann Talarico, contributing to the dynamic research environment at Sqz Biotechnologies. Their combined expertise fosters innovation and drives the development of cutting-edge solutions in biotechnology.

Conclusion

Alfonso Vicente-Suarez is a pioneering inventor whose work in intracellular delivery systems is shaping the future of immune response modification. His contributions to biotechnology are paving the way for new therapeutic possibilities.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…